Proposed pathways include modulation of multiple neurotransmitter systems (influencing serotonin, dopamine, norepinephrine, GABA, glutamate levels), possible involvement of NMDA receptors, alpha-1 adrenergic signaling (e.g., potentiating pineal acetyltransferase activity), inhibition of somatostatin release via dopaminergic routes, reduced ACTH/cortisol for stress buffering, and stimulated growth hormone or somatoliberin secretion
Mistake #4: Testing Your Limits with "Just One Bite" of Risky Foods Why it's wrong: Week one is not the time to discover that your new GLP-1 stomach doesn't handle pizza well
If you are also interested in how other injectable treatments compare, check out the Mounjaro vs Trulicity comparison for more context on weekly injectables
Similar results were found for semaglutide risk of MACE (death due to CVD, non-fatal MI, non-fatal stroke) HR 0.74 (95%CI 0.580.95) compared to placebo [26]